Clinical Trials Directory

Trials / Unknown

UnknownNCT05009186

Changing of Prostate Specific Antigen Value in Patients With Covid-19

Changing of PSA With Covid-19

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Saglik Bilimleri Universitesi · Academic / Other
Sex
Male
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

Detailed description

Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.

Conditions

Interventions

TypeNameDescription
OTHERPSA valueWe measure PSA value during and after covid-19 infection

Timeline

Start date
2020-04-01
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2021-08-17
Last updated
2021-08-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05009186. Inclusion in this directory is not an endorsement.